共 34 条
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
被引:136
作者:
Dongiovanni, P.
[1
]
Valenti, L.
[1
]
Rametta, R.
[1
]
Daly, A. K.
Nobili, V.
[2
]
Mozzi, E.
[1
]
Leathart, J. B. S.
Pietrobattista, A.
[2
]
Burt, A. D.
Maggioni, M.
[3
]
Fracanzani, A. L.
[1
]
Lattuada, E.
[1
]
Zappa, M. A.
[1
]
Roviaro, G.
[1
]
Marchesini, G.
[4
]
Day, C. P.
Fargion, S.
[1
]
机构:
[1] Univ Milan, Policlin MaRE IRCCS Hosp, I-20122 Milan, Italy
[2] Bambino Gesu Childrens Hosp & Res Ctr, Liver Unit, Rome, Italy
[3] Policlin IRCCS Milan, Milan, Italy
[4] Univ Alma Mater, Bologna, Italy
来源:
关键词:
ENPP1 K121Q POLYMORPHISM;
HEPATIC STEATOSIS;
SUBSTRATE-1;
GENE;
PC-1;
RESISTANCE;
PREVALENCE;
OBESITY;
RISK;
STEATOHEPATITIS;
METABOLISM;
D O I:
10.1136/gut.2009.190801
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Background/aims The aim of this study was to assess the effect of functional ENPP1(ectoenzyme nucleotide pyrophosphate phosphodiesterase 1)/PC-1 ( plasma cell antigen-1) and IRS-1 ( insulin receptor substrate-1) polymorphisms influencing insulin receptor activity on liver damage in non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, whose progression is associated with the severity of insulin resistance. Patients and methods 702 patients with biopsy-proven NAFLD from Italy and the UK, and 310 healthy controls. The Lys121Gln ENPP1/PC-1 and the Gly972Arg IRS-1 polymorphisms were evaluated by restriction analysis. Fibrosis was evaluated according to Kleiner. Insulin signalling activity was evaluated by measuring phosphoAKT levels by western blotting in a subset of obese non-diabetic patients. Results The ENPP1 121Gln and IRS-1 972Arg polymorphisms were detected in 28.7% and 18.1% of patients and associated with increased body weight/dyslipidaemia and diabetes risk, respectively. The ENPP1 121Gln allele was significantly associated with increased prevalence of fibrosis stage >1 and >2, which was higher in subjects also positive for the 972Arg IRS-1 polymorphism. At multivariate analysis, the presence of the ENPP1 121Gln and IRS-1 972Arg polymorphisms was independently associated with fibrosis >1 ( OR 1.55, 95% CI 1.24 to 1.97; and OR 1.57, 95% CI 1.12 to 2.23, respectively). Both polymorphisms were associated with a marked reduction of similar to 70% of AKT activation status, reflecting insulin resistance and disease severity, in obese patients with NAFLD. Conclusions The ENPP1 121Gln and IRS-1 972Arg polymorphisms affecting insulin receptor activity predispose to liver damage and decrease hepatic insulin signalling in patients with NAFLD. Defective insulin signalling may play a causal role in the progression of liver damage in NAFLD.
引用
收藏
页码:267 / 273
页数:7
相关论文